SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea
· Delayed Price · Currency is KRW 104,800
+800 (0.77%)
Apr 18, 2025, 3:30 PM KST
SK Biopharmaceuticals Market Cap
SK Biopharmaceuticals has a market cap or net worth of 8.21 trillion as of April 17, 2025. Its market cap has increased by 9.17% in one year.
Market Cap
8.21T
Enterprise Value
8.09T
Revenue
547.60B
Ranking
n/a
PE Ratio
34.09
Stock Price
104,800.00
Market Cap Chart
Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.21T, a decrease of -17.48%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2025 | 8,207.23B | -5.67% |
| Dec 30, 2024 | 8,700.60B | 10.66% |
| Dec 28, 2023 | 7,862.65B | 39.25% |
| Dec 29, 2022 | 5,646.39B | -25.82% |
| Dec 30, 2021 | 7,612.05B | -42.49% |
| Dec 30, 2020 | 13.23T | 33.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 34.28T |
| ALTEOGEN | 20.94T |
| Yuhan | 8,636.87B |
| HLB Co., Ltd. | 7,356.32B |
| Peptron | 4,195.85B |
| LigaChem Biosciences | 3,856.78B |
| PharmaResearch | 3,766.25B |